Development of a miRNA-seq based prognostic signature in lung adenocarcinoma

BACKGROUND: We utilized miRNAs expression and clinical data to develop a prognostic signature for patients with lung adenocarcinoma, with respect to their overall survival, to identify high-risk subjects based on their miRNA genomic profile. METHODS: MiRNA expressions based on miRNA sequencing and c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Siriwardhana, Chathura, Khadka, Vedbar S., Chen, John J., Deng, Youping
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325795/
https://ncbi.nlm.nih.gov/pubmed/30621620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5206-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller